On ECHEMI
Home > Drugs > Imatinib mesylate Registered Holders
Imatinib mesylate structure

Imatinib mesylate structure

Imatinib mesylate

Imatinib Mesylate is a tyrosine kinases inhibitor that inhibits c-Kit, Bcr-Abl, and PDGFR (IC50=100 nM) tyrosine kinases.

Find 54 Related Holders

ACEBRIGHT INDIA PHARMA PRIVATE LTD
United States United States

API Registration Country

API Active
RELIANCE LIFE SCIENCES PVT LTD
United States United States

API Registration Country

API Active
SHILPA PHARMA LIFESCIENCES LTD
United States United States

API Registration Country

API Active
LAURUS LABS LTD
United States United States

API Registration Country

API Active
MSN LABORATORIES PRIVATE LTD
United States United States

API Registration Country

API Active
APITORIA PHARMA PRIVATE LTD
United States United States

API Registration Country

API Active
ZYDUS LIFESCIENCES LTD
United States United States

API Registration Country

API Active
TAPI Croatia Industries Ltd.
Japan Japan

API Registration Country

API Active
Sumitomo Chemical Co.,Ltd
Japan Japan

API Registration Country

API Active
  • Country:

    Japan Japan
HETERO LABS LIMITED
India India

API Registration Country

API Active
  • Founded in:

    1989-03-10 00:00:00
  • Country:

    India India
  • Address:

    #7-2-A2, Industrial Estate, Sanath Nagar, Sanathnagar I E Balanagar Hyderabad TG 500018 IN
  • Registered Funds:

    2.8 billion INR
  • Email:

Recommended Suppliers of Imatinib mesylate
View 202 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.